Phenylpiracetam

Phenylpiracetam is a nootropic of the racetam family, known in clinical use by the trade name phenotropil and in the doping literature as carphedon or fonturacetam; chemically it is 2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide, the piracetam molecule with a phenyl group attached to the pyrrolidone ring ^[1][2]. That single aromatic addition is the defining structural change, and it makes phenylpiracetam substantially more potent by weight than piracetam while also giving the molecule stimulant-like and dopaminergic properties the parent compound lacks ^[2][3]. The compound is chiral, and its two enantiomers differ in activity, with the R-form carrying most of the memory-related effect ^[2].

Phenylpiracetam was developed in Russia, where phenotropil has been used as a prescription nootropic to improve physical condition and cognition, and it has been studied for endurance and cold resistance as well as amnesia ^[2][5]. Human clinical work from Russian centers has examined phenotropil in neurological settings, including as an add-on in the treatment of symptomatic post-traumatic epilepsy, where it was associated with improved cognitive function without the seizure aggravation seen with some nootropics ^[6]. Additional research describes nootropic and mitoprotective effects in models of impaired cognition ^[7].

In modern anti-doping regulation phenylpiracetam holds a notable place: carphedon was the first nootropic prohibited in sport, added to the banned list in 1998, and it is detectable in urine by standard doping-analysis methods ^[1][5]. Outside Russia and a handful of neighboring countries it is not an approved medicine, and it is instead sold internationally as a research chemical or nootropic dietary supplement, a category in which regulatory reviews have flagged it as an unauthorized ingredient ^[1]. It is most commonly encountered as a crystalline powder or in capsule and tablet form under names such as phenotropil, phenylpiracetam, and fonturacetam ^[1].

Phenylpiracetam is a phenyl-modified piracetam with a noticeable stimulant, focus-forward feel, which is why people like it for demanding days. A few sensible notes: it leans dopaminergic and mildly stimulant, so keep it away from other strong stimulants, MAOIs, or dopamine drugs, and go easy if you deal with uncontrolled high blood pressure, anxiety, insomnia, or heart issues; a choline source like Alpha-GPC or CDP-choline is the usual fix for racetam headaches. Tolerance to the kick builds fast, so it works best used now and then rather than daily. Athletes should note WADA bans it in competition (it tests as carphedon). Legally it's grey-market in much of the world and a prescription med in Russia and Eastern Europe.

Phenylpiracetam, known as phenotropil or carphedon, was developed in the Soviet Union in the 1980s by adding a phenyl group to the piracetam molecule, a modification that greatly increased potency and introduced a new dopaminergic mechanism.

It was created in part for the demands of cosmonauts and other personnel who needed to sustain performance under physical and psychological stress, and it later became a clinically used nootropic, marketed in the region as Phenotropil by the Latvian manufacturer Olainfarm.

Its performance-enhancing reputation drew the attention of anti-doping authorities, and carphedon was among the first cognitive enhancers prohibited in competitive sport, added to the banned list in 1998. Much of its modern mechanistic characterization, including the identification of the dopamine transporter as its principal molecular target, came from work by Zvejniece, Dambrova and colleagues at the Latvian Institute of Organic Synthesis.

Phenylpiracetam has a strong reputation as the most stimulant-leaning of the common racetams, with users reporting improved focus, motivation, physical endurance, and tolerance to cold and fatigue. That profile is now backed by a clear molecular story; unlike the milder, non-dopaminergic piracetam, phenylpiracetam selectively inhibits the dopamine transporter, which plausibly underlies its energizing character. Its athletic reputation is genuine enough that it is banned in sport, a fact worth respecting for anyone subject to drug testing, and tolerance to its stimulant effects can build with frequent use. On balance it is one of the better-studied and most distinctive racetams, valued for a dependable, driven quality that sets it apart from its parent compound.